Infographic: Bitter Pill -- Indian pharma's dependence on China
Coronavirus pandemic and border tensions have brought to light India's over-dependence on Chinese imports
- Jul 20, 2020,
- Updated Jul 20, 2020 5:06 PM IST
Over-dependence on low cost imports from China has prevented Indian pharma from being self-reliant, posing a severe health security risk. Even critical APIs, many of which are included in India's national list of essential medicines (NLEM) are being imported from China. This BusinessToday's infographic looks at Indian pharmaceutical sector's heavy reliance on the neighbouring country and what it needs to do to become 'pharmacy to the world'.
Also view: How Jio made Reliance net-debt free
Also view: How coronavirus has damaged job scene in India
Also view: How little Govt will spend of Rs 21 lakh cr stimulus package
Also view: Alcohol to the rescue
Also view: Has Sensex bottomed out?
Also view: What crude crash means for India
Also view: How coronavirus has hurt Indian economy
Over-dependence on low cost imports from China has prevented Indian pharma from being self-reliant, posing a severe health security risk. Even critical APIs, many of which are included in India's national list of essential medicines (NLEM) are being imported from China. This BusinessToday's infographic looks at Indian pharmaceutical sector's heavy reliance on the neighbouring country and what it needs to do to become 'pharmacy to the world'.
Also view: How Jio made Reliance net-debt free
Also view: How coronavirus has damaged job scene in India
Also view: How little Govt will spend of Rs 21 lakh cr stimulus package
Also view: Alcohol to the rescue
Also view: Has Sensex bottomed out?
Also view: What crude crash means for India
Also view: How coronavirus has hurt Indian economy